Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alberto L Moreno-Vega"'
Autor:
Yiraldine Herrera-Martínez, María José Contreras González, Sergio Pedraza-Arévalo, Maria del Carmen Guerrero Martínez, Ángela Rodrigo Martínez, Alberto González Menchen, Maria Angeles Blanco Molina, Maria Angeles Gálvez-Moreno, Alberto L. Moreno-Vega, Raúl M. Luque, Aura D. Herrera-Martínez
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2022)
Hypercalcemia is a common complication in cancer patients Mainly caused by Parathyroid hormone-related protein (PTHrP) secretion and metastasis. Calcitriol secretion is a rare source of hypercalcemia in solid tumors, especially in gastrointestinal st
Externí odkaz:
https://doaj.org/article/ff8de20aef5f4be58a6fcfba92e81d16
Autor:
Yiraldine, Herrera-Martínez, María José, Contreras González, Sergio, Pedraza-Arévalo, Maria Del Carmen, Guerrero Martínez, Ángela, Rodrigo Martínez, Alberto, González Menchen, Maria Angeles, Blanco Molina, Maria Angeles, Gálvez-Moreno, Alberto L, Moreno-Vega, Raúl M, Luque, Aura D, Herrera-Martínez
Publikováno v:
Frontiers in endocrinology. 12
Hypercalcemia is a common complication in cancer patients Mainly caused by Parathyroid hormone-related protein (PTHrP) secretion and metastasis. Calcitriol secretion is a rare source of hypercalcemia in solid tumors, especially in gastrointestinal st
Autor:
Amalia Palacios-Eito, Elvira Carmona-Asenjo, Alberto L Moreno-Vega, Rosa Ortega-Salas, Sonia García-Cabezas, Simona Espejo-Pérez, Macarena Centeno-Haro
Publikováno v:
World Journal of Clinical Oncology
Pulmonary artery intimal sarcoma (PAIS) is a rare tumor with a very poor prognosis. Clinical and radiological findings usually mimic thromboembolic disease, leading to diagnostic delays. The treatment of choice is surgery, and adjuvant chemotherapy a
Autor:
Juan de la Haba, Enrique Aguilar, Alberto L. Moreno-Vega, Carmen GarcÃa Durán, Isidoro Carlos Barneto Aranda, Pedro Sánchez Mauriño, Javier López-González
Publikováno v:
Journal of Clinical Oncology. 37:108-108
108 Background: Recently, nivolumab has been approval as 2nd-line treatment of non-small cell lung cancer (NSCLC) in our country. Data regarding its effectiveness or safety in real-life setting are publishing daily. Methods: 27 patients with advanced
Autor:
María Auxiliadora Gómez-España, Javier López-González, Alberto L. Moreno-Vega, Enrique Aranda-Aguilar, Barbara Manzanares-Martin, Rafael Gonzalez-Fernandez, Beatriz Chia-Delgado, Antonio Rodríguez-Ariza, Ignacio Porras-Quintela, Cristina Morales-Estevez, Juan de la Haba-Rodriguez, Maria Jose Ortiz-Morales, Maria T. Cano-Osuna
Publikováno v:
Frontiers in Immunology
Killer-cell immunoglobulin-like receptors (KIRs) regulate the killing function of natural killer cells, which play an important role in the antibody-dependent cell-mediated cytotoxicity response exerted by therapeutic monoclonal antibodies (mAbs). Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3be61b5abc8aaa273a6878ff1da0ff3
https://www.frontiersin.org/articles/10.3389/fimmu.2016.00561/pdf
https://www.frontiersin.org/articles/10.3389/fimmu.2016.00561/pdf
Autor:
E. Aranda-Aguilar, María Auxiliadora Gómez-España, J. de la Haba-Rodríguez, Barbara Manzanares-Martin, R. Serrano-Blanch, I. Porras-Quintela, Maria Jose Ortiz-Morales, M. Cano-Osuna, Alberto L. Moreno-Vega, Javier López-González, Rafael Gonzalez-Fernandez, Cristina Morales-Estevez
Publikováno v:
European Journal of Cancer. 51:S278